Gitlab Inc.: Form 10-Q for the period ended Apr 30, 2023
Filed with the SEC on Jun 6, 2023 and accepted by EDGAR at Jun 5, 2023, 17:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-02-01 to 2023-04-30 | $126.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-02-01 to 2023-04-30 | $13.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-02-01 to 2023-04-30 | $112.9m | us-gaap:GrossProfit |
| Research and development | 3 months2023-02-01 to 2023-04-30 | $50.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-02-01 to 2023-04-30 | −$58.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-02-01 to 2023-04-30 | $1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-02-01 to 2023-04-30 | −$52.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-02-01 to 2023-04-30 | −$0.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-02-01 to 2023-04-30 | −$0.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-02-01 to 2023-04-30 | 151,692,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-02-01 to 2023-04-30 | −$11.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-02-01 to 2023-04-30 | $256.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-04-30 | $315.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-04-30 | $1.12bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-04-30 | $1.16bn | us-gaap:Assets |
| Current liabilities | At period end2023-04-30 | $311.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-04-30 | $348.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-04-30 | $765.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-23-020942. Last ingested by Listed: Oct 30, 2026, 16:31 ET. Listed shows no prices and gives no investment advice.